JPH068249B2 - Topical agent for suppressing melanin production - Google Patents

Topical agent for suppressing melanin production

Info

Publication number
JPH068249B2
JPH068249B2 JP63140404A JP14040488A JPH068249B2 JP H068249 B2 JPH068249 B2 JP H068249B2 JP 63140404 A JP63140404 A JP 63140404A JP 14040488 A JP14040488 A JP 14040488A JP H068249 B2 JPH068249 B2 JP H068249B2
Authority
JP
Japan
Prior art keywords
extract
melanin production
glabrene
glabridin
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63140404A
Other languages
Japanese (ja)
Other versions
JPH01311011A (en
Inventor
龍彦 堤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MARUZEN SEIYAKU KK
Original Assignee
MARUZEN SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MARUZEN SEIYAKU KK filed Critical MARUZEN SEIYAKU KK
Priority to JP63140404A priority Critical patent/JPH068249B2/en
Publication of JPH01311011A publication Critical patent/JPH01311011A/en
Publication of JPH068249B2 publication Critical patent/JPH068249B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、メラニン生成抑制外用剤に関するものであ
る。なお、この明細書で外用剤とは、化粧料のほか、外
用に用いられる軟膏剤、ローション剤、リニメント剤、
乳剤などの医薬部外品を包含する。
TECHNICAL FIELD The present invention relates to an external preparation for suppressing melanin production. In addition, in this specification, in addition to cosmetics, the external preparations include ointments, lotions, liniments, which are used externally.
Includes quasi drugs such as emulsions.

〔従来の技術〕[Conventional technology]

皮膚が黒くなる原因の一つとして、アミノ酸の一種であ
るチロシンにチロシナーゼが作用することによる色素・
メラニンの生成がある。そこで、従来、アスコルビン
酸、プラセンターエキス、コウジ酸、桑白皮エキス、チ
ロシナーゼ活性阻害作用を有する各種動植物抽出物(た
とえば特開昭58−225004号公報、特開昭61−
12209号公報)等を化粧料に配合することにより、
上記原因による皮膚黒色化やシミ、ソバカスの発生を防
止することが提案され、一部、実施されている。しかし
ながら、アスコルビン酸類は酸化され易く、それを配合
した化粧料の変色、変臭を招くという欠点がある。また
動植物抽出物系のものは、その効果が十分でなく、ま
た、安定性や色、臭気等の点でも問題があり、実用可能
なものはほとんどない。
One of the causes of darkening of the skin is the pigment caused by the action of tyrosinase on tyrosine, which is a type of amino acid.
There is melanin production. Therefore, conventionally, ascorbic acid, placenta extract, kojic acid, mulberry bark extract, and various animal and plant extracts having a tyrosinase activity inhibitory action (for example, JP-A-58-225004, JP-A-61-
No. 12209 gazette) and the like are added to the cosmetics,
It has been proposed and partially implemented to prevent skin blackening, spots, and freckles due to the above causes. However, ascorbic acids are apt to be oxidized, which causes the discoloration and odor of cosmetics containing them. Further, animal and plant extract-based products are not sufficiently effective, and have problems in stability, color, odor, etc., and there are almost no practical ones.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明の目的は、上述のような現状に鑑み、従来公知の
チロシナーゼ活性阻害物質よりも少量ですぐれた作用を
示す物質を用いた使い易く且つ効果的なメラニン生成抑
制外用剤を提供することにある。
In view of the above-mentioned current situation, an object of the present invention is to provide an easy-to-use and effective external preparation for suppressing melanin production, which uses a substance exhibiting superior action in a smaller amount than conventionally known tyrosinase activity inhibitors. is there.

〔課題を解決するための手段〕[Means for Solving the Problems]

本発明によるメラニン生成抑制外用剤は、下記構造式の
グラブリジンまたは(および)グラブレンを有効成分と
して含有するものである。
The external preparation for suppressing melanin production according to the present invention contains glabridine or / and glabrene having the following structural formula as an active ingredient.

グラブリジンおよびグラブレンは、天然に甘草の1種Gl
ycyrrhiza glabra Linn var(ソ連、アフガン、トル
コカンゾウ)に微量含まれているが、その薬理作用につ
いての報告はなく、グラブリジンについて抗菌作用が、
またグラブレンについて抗酸化作用および抗菌作用が、
それぞれ知られているにすぎない。
Grabridine and Grabrene are naturally licorice Gl
It is contained in ycyrrhiza glabra Linn var (Soviet Union, Afghanistan, Turkish liquorice) in trace amounts, but there is no report on its pharmacological effect, and antibacterial effect on glabridin is
In addition, the antioxidant and antibacterial effects of glabrene,
Each is only known.

本発明者らは、グラブリジンおよびグラブレンが優れた
チロシナーゼ活性阻害作用を示すことを初めて見いだ
し、本発明を完成した。
The present inventors have for the first time found that glabridin and glabrene exhibit excellent tyrosinase activity inhibitory effects, and completed the present invention.

原料甘草・Glycyrrhiza glabra Linn varからグラブ
リジンおよびグラブレンを抽出するには、この甘草の根
部またはその水(もしくはアンモニア水)抽出残渣(た
とえばグリチルリチンを抽出した残渣)を有機溶媒で抽
出する。使用可能な抽出用有機溶媒の例としては、メタ
ノール、エタノール等の低級脂肪族アルコール;アセト
ン等の低級脂肪族ケトン;ジオキサン、エチルエーテル
等の低級脂肪族エーテル;塩化メチレン、クロロホルム
など炭素原子数1〜4のハロゲン化炭化水素;酢酸エチ
ル、酢酸n-ブチル、酢酸イソブチルなど炭素原子数3〜
7のエステル;n-ヘキサン、ベンゼン等の炭化水素類;
およびこれらの溶媒の2種以上の混合物がある。これら
の溶媒により上記甘草から有効成分を抽出するには、被
処理原料を約5〜15倍量の溶媒に浸漬して還流下に加
熱するか、約5〜15倍量の溶媒に常温で浸漬すればよ
い。得られる抽出液から溶媒を留去して得られる抽出物
は、茶褐色の固体である。この抽出物は、そのままで
も、チロシナーゼ活性阻害作用の点では十分利用可能な
ものであるが、必要ならば、脱臭、脱色等の精製処理を
施し、さらにはグラブリジンおよびグラブレンの純品に
近い純度まで精製してから用いてもよい。
To extract glabridin and glabrene from the raw material licorice Glycyrrhiza glabra Linn var, the root portion of this licorice or its water (or ammonia water) extraction residue (for example, the residue from which glycyrrhizin has been extracted) is extracted with an organic solvent. Examples of usable organic solvents for extraction include lower aliphatic alcohols such as methanol and ethanol; lower aliphatic ketones such as acetone; lower aliphatic ethers such as dioxane and ethyl ether; methylene chloride, chloroform and the like having 1 carbon atom. ~ 4 halogenated hydrocarbons; ethyl acetate, n-butyl acetate, isobutyl acetate, etc.
Ester of 7; hydrocarbons such as n-hexane and benzene;
And there are mixtures of two or more of these solvents. In order to extract the active ingredient from the licorice with these solvents, the raw material to be treated is immersed in about 5 to 15 times the amount of solvent and heated under reflux, or immersed in about 5 to 15 times the amount of solvent at room temperature. do it. The extract obtained by distilling the solvent from the obtained extract is a brown solid. This extract, as it is, is sufficiently usable in terms of tyrosinase activity inhibitory action, but if necessary, it is subjected to purification treatment such as deodorization and decolorization, and further to a purity close to that of pure glabridin and glabrene. It may be used after being purified.

本発明のメラニン生成抑制外用剤の形態は前述のように
多岐にわたり、色白作用を特徴とする化粧料の場合も、
たとえば化粧水、クリーム、乳液、パックなど、各種皮
膚用化粧料が有り得る。
The melanin production suppressing external preparation of the present invention has various forms as described above, and also in the case of cosmetics characterized by a whitening effect,
For example, there may be various skin cosmetics such as lotions, creams, emulsions and packs.

グラブリジンおよびグラブレンの好ましい配合量は、剤
種、期待されるメラニン生成抑制効果の程度などによつ
ても異なるが、通常0.0007〜0.05%程度が適
当である。
The preferred blending amount of glabridine and glabrene varies depending on the type of the agent, the expected degree of melanin production inhibitory effect, etc., but is usually 0.0007 to 0.05% or so.

〔実施例〕〔Example〕

以下、実施例を示して本発明を説明する。なお、実施例
1において用いた甘草は、いずれもGlycyrrhiza glabra
Linn varである。
Hereinafter, the present invention will be described with reference to examples. The licorice used in Example 1 was Glycyrrhiza glabra.
It is Linn var.

実施例1(甘草抽出例) 甘草の根の細切物100gを1の酢酸エチルとともに
2時間還流下に加熱して、酢酸エチル可溶成分を抽出し
た。抽出液を分離した抽出残渣について同様の操作を繰
り返し、合計1.8の抽出液を得た。この抽出液の溶
媒を留去し、さらに減圧乾燥して、グラブリジンおよび
グラブレンを含有する抽出物2.8gを得た。これを抽
出物Aとする。
Example 1 (licorice extraction example) 100 g of finely sliced licorice root was heated under reflux with 1 part of ethyl acetate for 2 hours to extract an ethyl acetate-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.8 extracts were obtained. The solvent of this extract was distilled off, and the residue was dried under reduced pressure to obtain 2.8 g of an extract containing glabridine and glabrene. This is designated as Extract A.

甘草根細切物100gを1の塩化メチレンに常温で5
時間浸漬して、塩化メチレン可溶成分を抽出した。抽出
液を分離した抽出残渣について同様の操作を繰返し、合
計1.7の抽出液を得た。この抽出液の溶媒を留去
し、さらに減圧乾燥して、グラブリジンおよびグラブレ
ンを含有する抽出物2.5gを得た。これを抽出物Bと
する。
100 g of licorice root shredded in 1 methylene chloride at room temperature
It was immersed for a period of time to extract the methylene chloride-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.7 extracts were obtained. The solvent of this extract was distilled off and further dried under reduced pressure to obtain 2.5 g of an extract containing glabridine and glabrene. This is designated as Extract B.

n-ヘキサン5部にアセトン2部を混合した抽出溶媒1
で甘草根細切物100gを2時間還流下に加熱して、溶
媒可溶成分を抽出した。抽出液を分離した抽出残渣につ
いて同様の操作を繰り返し、合計1.6の抽出液を得
た。この抽出液の溶媒を留去し、さらに減圧乾燥して、
グラブリジンおよびグラブレンを含有する抽出物2.3
gを得た。これを抽出物Cとする。
Extraction solvent 1 with 2 parts of acetone mixed with 5 parts of n-hexane
Then, 100 g of the licorice root shredded product was heated under reflux for 2 hours to extract a solvent-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.6 extracts were obtained. The solvent of this extract was distilled off, and further dried under reduced pressure,
Extract 2.3 containing Grabridine and Grabrene
g was obtained. This is designated as Extract C.

実施例2(グラブリジンおよびグラブレンの精製例) 実施例1による抽出物A2.8gを少量のクロロホルム
に溶解し、得られた溶液をシリカゲル(ワコーゲルC-3
00,和光純薬工業株式会社)にまぶしたのち、乾燥す
る。このシリカゲルを、あらかじめシリカゲル500g
を充填したカラムの上に積層充填し、クロロホルム/メ
タノール混合液(30:1)で溶出し、グラブリジン含
有画分およびグラブレン含有画分を採取した。目的物の
溶出は、薄層クロマトグラフイー(展開溶媒:クロロホ
ルム/メタノール;担体:メルク社シリカゲル60F;
検出方法:19%硫酸噴霧後加熱)によつて確認した。
各画分の溶媒を減圧下に留去して、固形のグラブリジン
画分0.8gおよびグラブレン画分0.16gを得た。
Example 2 (purification example of glabridin and glabrene) 2.8 g of the extract A according to Example 1 was dissolved in a small amount of chloroform, and the resulting solution was subjected to silica gel (Wakogel C-3
00, Wako Pure Chemical Industries, Ltd.) and dry. This silica gel is preliminarily treated with 500 g of silica gel.
Was stacked and packed on a column packed with and eluted with a chloroform / methanol mixture (30: 1) to collect a glabridine-containing fraction and a grabrene-containing fraction. Thin layer chromatography (developing solvent: chloroform / methanol; carrier: Merck silica gel 60F;
Detection method: 19% sulfuric acid spraying and heating).
The solvent of each fraction was distilled off under reduced pressure to obtain 0.8 g of solid glabridine fraction and 0.16 g of glabrene fraction.

このグラブリジン画分を少量のメタノールに溶解し、溶
液を逆相シリカゲル(30〜50メツシユ,ODSG-3,水
戸化学技術研究所製)にまぶして乾燥する。この逆相シ
リカゲルを、あらかじめ逆相シリカゲル200gを充填
したカラムの上に積層充填し、水/アセトニトリル(3
0:70)で分離溶出し、グラブリジン含有画分を採取
した。減圧下に溶媒を留去して、精製グラブリジン画分
0.45gを得た。これをさらにアセトン5mlに溶解
し、5℃に一夜冷却すると、グラブリジンの淡黄色結晶
0.4gが得られた。
This glabridin fraction is dissolved in a small amount of methanol, and the solution is sprinkled on reverse phase silica gel (30-50 mesh, ODSG-3, manufactured by Mito Chemical Research Laboratory) and dried. This reversed-phase silica gel was stacked and packed on a column previously packed with 200 g of reversed-phase silica gel, and water / acetonitrile (3
The mixture was separated and eluted at 0:70) and the glabridin-containing fraction was collected. The solvent was distilled off under reduced pressure to obtain a purified glabridine fraction 0.45 g. This was further dissolved in 5 ml of acetone and cooled to 5 ° C. overnight to obtain 0.4 g of pale yellow crystals of glabridin.

同様にしてグラブレン画分を精製し、精製グラブレン画
分0.1gを得、これをヘキサン3mlから再結晶させ
て、無色のグラブレン結晶0.08gを得た。
In the same manner, the Grabrene fraction was purified to obtain 0.1 g of the purified Grabrene fraction, which was recrystallized from 3 ml of hexane to obtain 0.08 g of colorless Grabrene crystals.

比較例1(異種甘草抽出物の調製) Glycyrrhiza echinata L.(スペインカンゾウ)、Glycy
rrhiza inflata Batal(中国シンキヨウカンゾウ)及び
Glycyrrhiza uralensis Fisher et De Candelle(中国
東北西北カンゾウ)について、それぞれ抽出物Aの場合
と同様の酢酸エチルによる抽出を行い、抽出物x、yお
よびzを得た。
Comparative Example 1 (Preparation of heterogeneous licorice extract) Glycyrrhiza echinata L. (Spanish Licorice), Glycy
rrhiza inflata Batal (Chinese Daylily) and
Glycyrrhiza uralensis Fisher et De Candelle (eastern northwestern Chinese licorice) was extracted with ethyl acetate in the same manner as in the case of the extract A to obtain extracts x, y and z.

比較例2(Glycyrrhiza glabra Linn varの水抽出物
の調製) 実施例1で用いたGlycyrrhiza glabra Linn varの根
を粗砕し、その100gを精製水1000mlに浸漬し、
蒸気浴上で2時間加熱して水溶性成分を抽出した。さら
に、抽出液を分離した残渣について同様の抽出操作を行
い、抽出液合計18000mlを得た。これを減圧下で濃
縮したのち減圧乾燥して、抽出物dを得た(収量20.
6g)。
Comparative Example 2 (Preparation of water extract of Glycyrrhiza glabra Linn var) The root of Glycyrrhiza glabra Linn var used in Example 1 was roughly crushed, and 100 g thereof was immersed in 1000 ml of purified water,
The water-soluble components were extracted by heating on a steam bath for 2 hours. Furthermore, the same extraction operation was performed on the residue from which the extract was separated, and a total of 18000 ml of the extract was obtained. This was concentrated under reduced pressure and then dried under reduced pressure to obtain an extract d (yield 20.
6g).

実施例3 上記各例で得られた抽出物A〜C、dおよびx〜z、グ
ラブリジンおよびグラブレン(結晶化品)、アスコルビ
ン酸について、チロシナーゼ阻害活性を測定した。測定
法は次のとおりである。
Example 3 The tyrosinase inhibitory activity was measured for the extracts A to C, d and x to z, glabridin and glabrene (crystallized products), and ascorbic acid obtained in each of the above examples. The measuring method is as follows.

[試薬] A:L-チロジン溶液(1.0mg/ml)0.5ml B:M/15リン酸緩衝液(pH6.8)2.0ml C:1%硫酸銅溶液0.05ml D:チロシナーゼ溶液(6mg/100ml)0.5ml [試料溶液] 試料をエタノールに溶解した後、M/50リン酸緩衝液で希
釈する。1回2mlを使用。
[Reagent] A: L-tyrosine solution (1.0 mg / ml) 0.5 ml B: M / 15 phosphate buffer (pH 6.8) 2.0 ml C: 1% copper sulfate solution 0.05 ml D: Tyrosinase solution (6 mg / 100 ml) 0.5 ml [Sample solution] The sample is dissolved in ethanol and then diluted with M / 50 phosphate buffer. Use 2 ml once.

[操作] 試料溶液にA、B、C、Dの各液を加え、37℃で1
時間インキユベートしたのち640nmの吸光度Atを測定
する。
[Operation] Add each of A, B, C, and D solutions to the sample solution, and add 1 at 37 ° C.
Measuring the absorbance A t of 640nm After time Inkiyubeto.

E液の代わりにm/50リン酸緩衝液2.0mlを加え、
と同様に操作して、640nmの吸光度Abを測定する。
Add 2.0 ml of m / 50 phosphate buffer instead of solution E,
Using the same method as, measuring the absorbance A b of 640 nm.

D液の代わりに精製水を0.5ml加え、と同様に操
作して、640nmの吸光度Aoを測定する。
Purified water (0.5 ml) is added instead of the liquid D, and the same operation as in (4) is performed to measure the absorbance A o at 640 nm.

種々の濃度の試料溶液について上記測定を行い、次式
によるチロシナーゼ阻害率が50%になる試料添加量を
内挿法で求める。
The above-mentioned measurement is carried out for sample solutions having various concentrations, and the sample addition amount by which the tyrosinase inhibition rate by the following formula is 50% is determined by the interpolation method.

また、上記各抽出物について、高速液体クロマトグラフ
イーによりグラブリジンおよびグラブレンの定量を行な
つた。分析条件は次のとおりである。まず試料約25mg
を精秤し、これをエタノールに溶かして全量を100ml
とする。別に、グラブリジンおよびグラブレンの標準液
(濃度約4mg/100mlエタノール)を用意する。試料溶液
と標準液を下記条件の高速液体クロマトグラフイーにか
ける。
Further, with respect to each of the above extracts, glabridin and glabrene were quantified by high performance liquid chromatography. The analysis conditions are as follows. First about 25mg of sample
Is precisely weighed, dissolved in ethanol and the total volume is 100 ml.
And Separately, a standard solution of glabridin and glabrene (concentration about 4 mg / 100 ml ethanol) is prepared. The sample solution and standard solution are subjected to high performance liquid chromatography under the following conditions.

カラム:オクタデシルシリル化シリカゲル (Wakopak 5C18,4.6mmφ×250mm) カラム温度:40℃ 移動相:アセトニトリル−2%酢酸(60:40) 流速1ml/min 検出器:紫外吸光光度計(波長282nm) 注入量:20μl 測定結果は表1のとおりであつた。Column: Octadecyl silylated silica gel (Wakopak 5C18, 4.6 mmφ x 250 mm) Column temperature: 40 ° C Mobile phase: Acetonitrile-2% acetic acid (60:40) Flow rate 1 ml / min Detector: Ultraviolet absorptiometer (wavelength 282 nm) Injection amount : 20 μl The measurement results are shown in Table 1.

実施例4 エタノール 15.0% モノラウリン酸ポリオキシエチレンソルビタン (20EO) 1.0 パラオキシ安息香酸 0.2 香料 0.2 抽出物A 0.02 精製水 72.6 グリセリン 5.0 1,3-ブチレングリコール 6.0 色素 適量 上記(室温にて混合し均一溶液としたもの)を用意
し、を攪拌しつつを徐々に添加して、シミ防止化粧
水を調製した。
Example 4 Ethanol 15.0% Polyoxyethylenesorbitan monolaurate (20EO) 1.0 Paraoxybenzoic acid 0.2 Perfume 0.2 Extract A 0.02 Purified water 72.6 Glycerin 5.0 1,3-butylene Glycol 6.0 Dye An appropriate amount of the above (prepared as a uniform solution by mixing at room temperature) was prepared, and was slowly added with stirring to prepare a stain-proof lotion.

この化粧水を30〜40才の女性20人に毎日被用させ
た。2週間使用後のシミの軽減度を調べたところ、効果
あり7名、やや効果あり10名、効果なし3名で、有効
率は85%であり、優れたシミ防止作用を有することが
確認された。
This lotion was applied to 20 women aged 30 to 40 every day. When the degree of reduction of the spots after 2 weeks of use was examined, it was confirmed that 7 people had an effect, 10 people had an effect, 3 people had no effect, and the effective rate was 85%, which had an excellent anti-spot effect. It was

実施例5 ステアリン酸 15% セタノール 1.0 グラブリジン 0.003 水酸化カリウム 0.7 グリセリン 5.0 プロピレングリコール 3.0 殺菌・防腐剤 適量 精製水 75% 香料 0.3 上記を82℃に、を80℃に、それぞれ加熱溶解
し、攪拌しながらをに徐々に加えて乳化を行う。5
0℃にてを添加し、30℃まで冷却して、シミ、ソバ
カス防止バニシングクリームを調製した。
Example 5 Stearic acid 15% Cetanol 1.0 Glabridine 0.003 Potassium hydroxide 0.7 Glycerin 5.0 Propylene glycol 3.0 Sterilizing / preservative suitable amount Purified water 75% Perfume 0.3 The above to 82 ° C. Each of them is melted by heating at 80 ° C. and gradually added while stirring to emulsify. 5
Was added at 0 ° C. and cooled to 30 ° C. to prepare a spot and freckle prevention vanishing cream.

実施例6 スクワラン 5.0% ワセリン 2.0 サラシミツロウ 0.5 セスキオレイン酸ソルビタン 0.8 ポリオキシエチレンオレイルエーテル (20EO) 1.2 グラブレン 0.01 殺菌・防腐剤 適量 プロピレングリコール1%水溶液 5.0 エタノール 3.2 カルボキシビニルポリマー(1%水溶液) 18.0 水酸化ナトリウム 0.1 精製水 63.9 香料 0.3 上記を75℃に、を73℃に、それぞれ加熱溶解
し、攪拌しながらをに徐々に加えて乳化させる。そ
の後を加えてから30℃に冷却して、シミ、ソバカス
防止エモリエントローシヨンを調製した。
Example 6 Squalane 5.0% Vaseline 2.0 Sarah beeswax 0.5 Sorbitan sesquioleate 0.8 Polyoxyethylene oleyl ether (20EO) 1.2 Grabrene 0.01 Sterilizer / preservative Appropriate amount Propylene glycol 1% aqueous solution 5 0.0 Ethanol 3.2 Carboxyvinyl polymer (1% aqueous solution) 18.0 Sodium hydroxide 0.1 Purified water 63.9 Perfume 0.3 The above ingredients were heated and dissolved at 75 ° C. and 73 ° C., respectively, and stirred. While gradually adding, emulsify. After the addition, the mixture was cooled to 30 ° C. to prepare a stain- and freckle-preventing emollient lotion.

〔発明の効果〕〔The invention's effect〕

実施例3の結果から明らかなように、グラブリジンおよ
びグラブレンはチロシナーゼ阻害活性が強く、少量で有
効であり、副作用もなく、淡黄色(グラブリジン)また
は無色(グラブレン)であり、また、化学的にも安定な
物質であるから、多くの化粧料、外用剤等に自由に配合
することができる。したがつて本発明によれば、従来よ
りも使い易く効果も優れた様々なメラニン生成抑制外用
剤を提供することが可能になる。
As is clear from the results of Example 3, glabridin and glabrene have strong tyrosinase inhibitory activity, are effective in a small amount, have no side effects, are pale yellow (glabridine) or colorless (glabrene), and are chemically chemically active. Since it is a stable substance, it can be freely mixed with many cosmetics, external preparations and the like. Therefore, according to the present invention, it becomes possible to provide various external preparations for suppressing melanin production, which are easier to use and more effective than conventional ones.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】グラブリジンを有効成分として含有するこ
とを特徴とするメラニン生成抑制外用剤。
1. An external preparation for suppressing melanin production, which contains glabridin as an active ingredient.
【請求項2】グラブレンを有効成分として含有すること
を特徴とするメラニン生成抑制外用剤。
2. An external preparation for suppressing melanin production, which comprises glabrene as an active ingredient.
JP63140404A 1988-06-09 1988-06-09 Topical agent for suppressing melanin production Expired - Lifetime JPH068249B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63140404A JPH068249B2 (en) 1988-06-09 1988-06-09 Topical agent for suppressing melanin production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63140404A JPH068249B2 (en) 1988-06-09 1988-06-09 Topical agent for suppressing melanin production

Publications (2)

Publication Number Publication Date
JPH01311011A JPH01311011A (en) 1989-12-15
JPH068249B2 true JPH068249B2 (en) 1994-02-02

Family

ID=15267977

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63140404A Expired - Lifetime JPH068249B2 (en) 1988-06-09 1988-06-09 Topical agent for suppressing melanin production

Country Status (1)

Country Link
JP (1) JPH068249B2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195683B2 (en) * 1993-03-01 2001-08-06 丸善製薬株式会社 Skin cosmetics
JPH0812518A (en) * 1994-06-27 1996-01-16 Maruzen Pharmaceut Co Ltd Skin cosmetic
US5874463A (en) 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
CA2334335A1 (en) * 1998-06-08 1999-12-16 Fytokem Products Inc. Tyrosinase inhibitors from plants
FR2822067B1 (en) * 2001-03-16 2006-05-26 Led Evolution Dermatolog DEPIGMENTING DERMATOLOGICAL COMPOSITION BASED ON GLABRIDINE
CN101198341A (en) 2005-03-15 2008-06-11 丸善制药株式会社 Antipyrotic
CA2706797A1 (en) * 2007-11-19 2009-05-28 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
US9241893B2 (en) 2007-11-19 2016-01-26 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
US9364424B2 (en) 2007-11-19 2016-06-14 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
FR3019040B1 (en) * 2014-03-31 2016-03-11 Arkema France COSMETIC COMPOSITION FOR SKIN LIGHTENING
CN106687100B (en) * 2014-09-12 2020-09-04 宝洁公司 Cosmetic compositions and methods for inhibiting melanin synthesis
JP6873598B2 (en) * 2015-12-22 2021-05-19 ロレアル Improved topical delivery system for active ingredients
CN105902423A (en) * 2016-04-15 2016-08-31 欧标(广州)化妆品有限公司 Whitening mask composition for uniformizing skin color and brightening skin
CN112584826A (en) * 2018-07-30 2021-03-30 联合利华知识产权控股有限公司 Compositions comprising active plant ingredients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214721A (en) * 1984-04-06 1985-10-28 Inahata Koryo Kk Cosmetic composition for preventing liver-spot
JPS61122209A (en) * 1984-11-16 1986-06-10 Osaka Chem Lab Cosmetic composition for preventing skins from staining and spotting

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
奥田拓也編「天然薬物辞典」株式会社広川書店発行(昭和61年4月15日)P.99〜100

Also Published As

Publication number Publication date
JPH01311011A (en) 1989-12-15

Similar Documents

Publication Publication Date Title
JPH068249B2 (en) Topical agent for suppressing melanin production
JPH04342519A (en) Skin cosmetic
JPH05306231A (en) Skin external preparation
JP2952636B2 (en) Melanin production inhibitor, method for producing the same, and whitening cosmetic containing the same
JPS63316711A (en) Beautifying and whitening cosmetic
JP2810107B2 (en) Cosmetic composition for skin
JP3800611B2 (en) Whitening agent or pigmentation ameliorating agent
JP2749218B2 (en) Cosmetic composition for whitening
JPS63135310A (en) Cosmetic
JPH0899891A (en) Skin external agent
JPH10287544A (en) Anti-pigmentation agent, and skin cosmetic and preparation for external use for skin
JPH07157494A (en) New isoflavone glycoside and cosmetic containing the same
JPH05124950A (en) Beautifying and whitening cosmetic composition
JP3052104B2 (en) Skin cosmetics
JPH03127714A (en) Skin cosmetic
JP2004345969A (en) Tyrosinase inhibitor and bleaching cosmetic using the same
JPH08119843A (en) Suppressant for melanin
KR100757130B1 (en) Cosmetic for skin whitening containing verazine and epi-verazine with inhibitory activity of melanin formation
JPH07238011A (en) Skin-beautifying cosmetic composition
JP4457133B2 (en) External preparation for skin and whitening agent
JPH01139517A (en) Cosmetic
JP4319417B2 (en) Melanin production deficiency treatment
JP2000256175A (en) Cosmetic composition
JPH06321760A (en) Skin beautifying agent
JP3150841B2 (en) External preparation for skin

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080202

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090202

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090202

Year of fee payment: 15